Mars to invest $2B into U.S. manufacturing through 2026
This builds on the $6B that the company has already allocated towards U.S.-based manufacturing over the past five years.
Mars, Incorporated, the maker of brands including Royal Canin®, M&M’S®, SNICKERS®, Ben’s Original™, PEDIGREE®, and SHEBA®, announced plans to invest an estimated $2 billion into its U.S. manufacturing operations by the end of 2026.
The global food, pet, and snacking leader said the multi-billion-dollar investment builds on its continued commitment to domestic production. Currently, 94% of Mars products sold in the U.S. are made locally, and the company has already invested more than $6 billion into U.S. manufacturing over the past five years.
“This investment is about building a stronger, more resilient business in the U.S. – one that can grow with our consumers, deliver for our partners, and create lasting economic impact in the communities where we operate,” said Claus Aagaard, CFO of Mars, Incorporated. “The U.S. is our biggest and most important market, and a key engine of growth for the long term – not only through our legacy manufacturing footprint but also through the expansion of strategic acquisitions like Nature’s Bakery, which is already scaling quickly. That’s why we’ve committed $6 billion to U.S. manufacturing in the last five years, with another $2 billion planned by the end of next year.”
Part of the new investment includes a $240 million facility for Nature’s Bakery in Salt Lake City, Utah, which opens Tuesday. The 339,000-square-foot site will create more than 230 jobs and is expected to produce nearly one billion bars annually.
Earlier this year, Mars also opened a $450 million Royal Canin® dry pet food facility in Lewisburg, Ohio. The plant is the brand’s largest dry pet food factory globally and is expected to create up to 270 new jobs in the area.
Mars, a privately held, family-owned company, has been based in the U.S. for more than a century. The company operates in 49 states, employs more than 70,000 people, and runs 38 factories as well as veterinary clinics, labs, and 16 global and regional offices. In the past five years, Mars has added over 9,000 U.S.-based associates.
